The crisis over hemophilia medicines in Jammu and Kashmir is not a logistical hiccup rather it’s a collapse of accountability. When hospitals repeatedly raise requisitions for Factor VIII, Factor IX, Emicizumab, and Von Willebrand factor, and receive silence in return, the failure is not technical but administrative. For patients whose lives depend on these clotting factors, every day of delay is a day of danger. Medicines lying in warehouses while patients bleed is not inefficiency but denial of care.
Hemophilia is a rare but life‑threatening condition. Patients lack the proteins that allow blood to clot, meaning even minor injuries can trigger prolonged bleeding. Treatment depends on timely infusion of clotting factors. Factor VIII and IX are not optional drugs; they are lifelines. Emicizumab, a newer therapy, has transformed care globally by reducing bleeding episodes. In Kashmir, however, these medicines have become symbols of systemic neglect. Hospitals cannot treat emergencies without them, and families are left to navigate uncertainty while supplies remain locked behind bureaucratic walls.
The affidavit from the medical college makes the picture stark; procurement agencies ignored reminders, leaving hospitals stranded without essential drugs. This inertia has forced patients into uncertainty and doctors into helplessness. Litigation has now become the only route to secure medicines, exposing a health system where supply chains stall not because of scarcity but because of indifference. The disconnect between availability and delivery is not a matter of logistics; it is a failure of governance.
The court’s intervention demanding personal appearance and affidavit from the procurement head is a reminder that responsibility cannot be diffused across departments. Judicial oversight has become necessary because administrative accountability has failed. The directive to release medicines without delay is more than a legal order; it is an acknowledgment that patient welfare cannot wait for procedural clearance. Courts should not have to compel the release of life‑saving drugs, yet here they are forced to act as guarantors of basic health rights.
But the larger issue is systemic as the essential medicines must move on strict timelines, with transparent tracking of requisitions and deliveries. Hospitals should not depend on repeated reminders; the system should anticipate demand and act before shortages occur.
The government must now move beyond reactive firefighting. A binding action plan is needed; timelines for procurement, monitoring mechanisms for distribution, and personal accountability for lapses. Stocks lying unused while patients suffer is governance at its weakest. Medicines must be released immediately, and future procurement must be structured to prevent recurrence. This requires digitized tracking systems, real‑time dashboards, and clear escalation protocols when requisitions are ignored. Without such reforms, the cycle of shortage, litigation and judicial intervention will repeat endlessly.
Health delivery is not only about infrastructure but about responsiveness. Kashmir has hospitals, doctors and trained staff, but without medicines, the system collapses. Patients must have certainty that treatment will be available when needed. Delay erodes trust and undermines the credibility of public health institutions. Families already burdened by the emotional and financial weight of chronic illness cannot be asked to shoulder the additional stress of bureaucratic indifference.
Judicial intervention has opened a window for reform. The responsibility now lies with the authorities to act decisively, eliminate delay, and ensure that patient welfare is placed at the center of the system. Procurement agencies must be held to binding timelines, and accountability must be personal, not diffused. Every reminder ignored is a breach of duty; every day of delay is a denial of care. The crisis in Kashmir is not an isolated incident but part of a recurring pattern across India, where procurement delays undermine patient care and the structural reform is the only way forward.
